Anat Cohen-Dayag | |
|---|---|
| Nationality |  Israel |
| Alma mater | Weizmann Institute of Science Ben-Gurion University |
| Scientific career | |
| Fields | biochemist |
Anat Cohen-Dayag is an Israeli businesswoman. She is president and chief executive officer of the Israeli biotechnology firm Compugen Ltd, a company involved in drug discovery. She previously worked as a scientist at the R&D department of Orgenics.
Education
She holds a B.Sc. in Biology from the Ben-Gurion University, and has obtained an MSc in Chemical Immunology and a PhD in Biological Chemistry from the Weizmann Institute of Science.[1][2][3]
References
- ↑ "Anat Cohen Dayag - Forbes". People.forbes.com. 2012-04-18. Archived from the original on 2011-06-11. Retrieved 2012-08-14.
- ↑ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". FierceBiotech. Retrieved 2012-08-14.
- ↑ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". www.fiercebiotech.com. Retrieved 2021-03-14.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.